Sanexus
Sanexus develops Asta, an agentic AI-powered digital health platform delivering adaptive supportive care, symptom monitoring, and validated PRO capture (PRO-CTCAE, EORTC QLQ-C30) for oncology patients between clinical visits. It sells B2B subscriptions to cancer centers, pharma clinical trial sponsors, and academic research institutions.
- Company typePrivate
- Founded2025
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Sanexus does
Sanexus is a privately held, founder-led digital health company headquartered in New York that has developed Asta, an agentic AI-powered platform for supportive oncology care. Asta delivers adaptive, context-aware emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits; it administers validated patient-reported outcome instruments (PRO-CTCAE, EORTC QLQ-C30), tracks symptoms and quality-of-life continuously, and escalates to the clinical team when safety thresholds are met. The platform connects to electronic health records — including Epic via MyChart — through SMART on FHIR standards-based APIs, and runs on AWS infrastructure with Amazon Bedrock providing AI inference for its conversational agent. Asta operates as a Business Associate under HIPAA-compliant controls including encryption in transit, access controls, audit logging, and regular security reviews.
The company sells Asta on a B2B subscription-based SaaS model under Terms of Service effective May 26, 2026, using a direct enterprise sales motion with Request a Demo, Pilot Consultation, and Get in Touch conversion points. Pricing is not publicly disclosed and is quote-based. Three customer segments are targeted: oncology providers seeking to extend supportive care reach without adding staff; life sciences companies running oncology clinical trials that need real-time participant support, PRO capture, adherence improvement, and earlier safety signal detection; and academic research institutions and grant-funded teams (including NIH and ARPA-H applicants) needing configurable assessment protocols and longitudinal data capture for digital health intervention research. Research collaborations with Cornell Tech and the Jacobs Technion-Cornell Institute support the academic vertical.
Sanexus was founded by Malwina Lewicka, PhD (Co-Founder & CEO, health psychologist with a postdoctoral fellowship in Psycho-Oncology at Memorial Sloan Kettering Cancer Center) and Michael Federico (Co-Founder & CTO, software engineer with a BS in Computer Science from the University of Notre Dame and conversational AI experience in financial services). Stated headcount is 1–10 with only the two founders confirmed; no funding rounds, paying customers, or revenue figures are disclosed in the available sources. The company is incorporated in New York and operates as Sanexus, Inc.
Sanexus firmographics
Firmographics- Name
- Sanexus
- Legal name
- Sanexus, Inc.
- Website
- https://sanexus.ai
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Sanexus develops Asta, an agentic AI-powered digital health platform delivering adaptive supportive care, symptom monitoring, and validated PRO capture (PRO-CTCAE, EORTC QLQ-C30) for oncology patients between clinical visits. It sells B2B subscriptions to cancer centers, pharma clinical trial sponsors, and academic research institutions.
- Ownership category
- akta.pro rank
Sanexus industry classification
Industry- Product category
- Digital Health / Supportive Oncology Care Software
- NAICS
- Computer Systems Design Services (541512), Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)
- SIC
- Services-Health Services (8000), Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
- akta.pro industry
- Oncology Remote Symptom Monitoring & Care NavigationHealthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) PlatformsOncology Telemedicine PlatformsHealthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
Keywords
Where Sanexus is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Sanexus business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- Subscription-based SaaS: B2B subscription model for oncology providers, life sciences companies, and research institutions. Terms of Service references 'Subscription and Fees' section indicating recurring revenue. Pricing not publicly disclosed; likely tiered by provider size or patient volume.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Sanexus product offering
Product offeringCore offering
Sanexus develops Asta, an agentic AI-powered digital healthcare platform that delivers adaptive, real-time emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits. The platform is sold as a B2B subscription to oncology providers, life sciences companies running oncology clinical trials, and academic research institutions, and combines conversational AI, validated PRO instrument assessments (PRO-CTCAE, EORTC QLQ-C30), early adverse event detection with clinical escalation, and SMART on FHIR EHR integration with Epic.
Product overview
Sanexus offers a single unified platform product called Asta — an AI-powered digital healthcare companion for supportive oncology care. The platform extends care between clinical encounters through adaptive AI-driven conversations that deliver personalized support, symptom tracking, validated assessments (PRO-CTCAE, EORTC QLQ-C30), and clinical escalation when safety thresholds are met. Asta serves three segments: oncology providers, life sciences companies (clinical trials), and research institutions.
Differentiator
Problem solved
Functional benefit
Brands
- Asta: AI-powered supportive oncology care platform that delivers emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits.
Products and services
- Asta Agentic AI-powered digital healthcare platform for supportive oncology care. Delivers adaptive, real-time emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits. Features context-aware intelligence, proactive personalized information delivery, PRO instrument integration (PRO-CTCAE, EORTC QLQ-C30), early adverse event detection with clinical escalation, and SMART on FHIR integration with Epic/MyChart. Sold as a B2B subscription to oncology providers, life sciences companies running oncology clinical trials, and academic research institutions.
Quantifiable outcome
- 80%+ of cancer patients report unmet supportive care needs, representing the addressable market problem Asta addresses
- +2 more outcomes
Companies that use Sanexus
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Sanexus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature7 records
Sanexus partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Cornell TechcoreResearch collaboration with Cornell Tech on digital health technology development. Cornell Tech is a graduate-level institution founded by Technion-Israel Institute of Technology and Cornell University, focused on technology and entrepreneurship.
- Jacobs Technion-Cornell InstitutecoreAcademic partnership with the Jacobs Technion-Cornell Institute at Cornell Tech for advancing digital health interventions research and development.
- Epic (via MyChart)coreEHR integration partnership enabling patients to connect Asta to their Epic MyChart account. Uses SMART on FHIR standards-based APIs to exchange demographic data, conditions, medications, lab results, vital signs, allergies, procedures, and care plans.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Sanexus competitors and assessment
Company assessmentDirect peers
- Pack Health: Digital health coaching platform providing condition-specific (including oncology) one-on-one coaching and structured support between visits. Comparable in serving the same between-visit supportive care gap and selling into the same provider and pharma channels.
- Force Therapeutics: Digital care platform delivering structured, episode-based patient engagement and PRO capture across musculoskeletal and chronic conditions. Comparable in using validated PROs, EHR integration, and enterprise sales to provider systems, though focused on orthopedics rather than oncology.
- Jasper Health: Digital oncology platform providing personalized supportive care, symptom management, and care navigation to cancer patients between visits. Most directly comparable peer because it targets the same buyer (oncology providers), the same patient population, and the same unmet need (between-visit supportive care).
- Navigating Cancer: Oncology patient engagement platform serving cancer centers with symptom monitoring, distress screening, and care management tools. Comparable because it sells to the same oncology provider buyers and operates in the same distress screening / supportive care gap that Asta targets.
- Carevive Systems: Oncology care management and patient-reported outcomes platform used by cancer centers and life sciences companies for symptom monitoring, distress screening, and value-based care documentation. Closely comparable because it serves both oncology providers and pharma trial sponsors.
- Memora Health: AI-powered patient engagement and care navigation platform that automates outreach, symptom monitoring, and care team escalation across complex care journeys. Comparable as an enterprise health-tech platform delivering between-visit AI-driven patient communication and escalation.
Emerging players
- Hippocratic AI: Healthcare-focused LLM company building agentic AI agents for patient-facing interactions across multiple clinical use cases. Comparable as a peer in the agentic-AI-for-healthcare category, though Hippocratic targets a broader set of conditions and is better funded.
- Vivorcare: AI-powered oncology patient support and care companion app delivering personalized education, symptom tracking, and emotional support between visits. Comparable as an AI-native oncology supportive care platform targeting similar patient/provider use cases, though likely smaller and earlier stage.
Broad incumbents
- Flatiron Health: Roche-owned oncology technology and real-world data platform with deep penetration across US cancer centers, EHR integration, and life sciences trial services. Comparable as a much larger incumbent competing for the same oncology provider and pharma budgets, though it focuses more on data and research enablement than between-visit patient support.
- Tempus AI: AI-powered precision medicine company with a large oncology footprint spanning molecular profiling, clinical trial matching, and provider-facing decision support. Comparable as a deep-pocketed AI-oncology player, though it focuses more on clinical decision support than patient-facing supportive care.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Sanexus social profiles
Digital presenceSanexus compliance and trust
Trust signalCompliance1 record
Sanexus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sanexus leadership team
Management profileNumber of profiles
Profiles2 records
Sanexus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sanexus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sanexus
What does Sanexus do?
Sanexus develops Asta, an agentic AI-powered digital healthcare platform that delivers adaptive, real-time emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits. The platform is sold as a B2B subscription to oncology providers, life sciences companies running oncology clinical trials, and academic research institutions, and combines conversational AI, validated PRO instrument assessments (PRO-CTCAE, EORTC QLQ-C30), early adverse event detection with clinical escalation, and SMART on FHIR EHR integration with Epic.
Is Sanexus a public or private company?
Sanexus is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Sanexus founded?
Sanexus was founded in 2025. It employs 1 to 10 people.
Where is Sanexus based?
Sanexus is headquartered in New York, United States, in the North America region.
How does Sanexus make money?
One revenue line is on record: subscription-based SaaS.
Who are Sanexus's main competitors?
Direct peers on record are Pack Health, Force Therapeutics, Jasper Health, Navigating Cancer, Carevive Systems and Memora Health. Emerging players are Hippocratic AI and Vivorcare. Broad incumbents are Flatiron Health and Tempus AI.
Does Sanexus have an API?
No public API is recorded for Sanexus.
What industry is Sanexus in?
Sanexus's product category is Digital Health / Supportive Oncology Care Software. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation, with a secondary code of HLALAGAH, Oncology Telemedicine Platforms. Its NAICS code is 541512 and its SIC code is 8000.